Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact de caractéristiques cytogénétiques défavorables spécifiques sur les résultats après allogreffe de cellules hématopoïétiques dans le syndrome myélodysplasique avec cytogénétique de très mauvais pronostic : une étude du Chronic Malignancies Working Party de l'EBMT

Études rétrospectives

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Prevention and management of conditioning related skin toxicity in paediatric HSCT patients

Closed Survey/Study

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Prévention et gestion de la toxicité cutanée liée à la préparation chez les patients pédiatriques en greffe de cellules souches hématopoïétiques (HSCT)

Toutes les maladies

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Machine Learning grading system for acute graft-versus host disease

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Steroid refractory acute graft-versus-host disease - survey

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Renal failure in aplastic anemia

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Beatrice Drexler

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients

Non-interventional Prospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Immunosuppressive Treatment (IST)

Investigateur principal

Régis Peffault de Latour, Antonio M. Risitano

Real life analysis BV use as consolidation therapy in HL with high risk post ASCT

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Mariana Bastos Oreiro

Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis.

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Miguel-Angel Perales

Allogeneic Stem Cell TransplantationIn NK/ T-cell lymphoma

Retrospective Studies

Lymphoma Working Party (LWP)

Type de traitement

Investigateur principal

Norbert Schmitz

Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Jacopo Peccatori